Page last updated: 2024-08-24

irinotecan and n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide

irinotecan has been researched along with n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asada, M; Kusano, K; Owa, T; Ozawa, Y; Yokoi, A; Yoshimatsu, K	1

Other Studies

1 other study(ies) available for irinotecan and n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide

Article	Year
Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatment. Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:5 Topics: Animals; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Camptothecin; Cell Line, Tumor; Colorectal Neoplasms; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Irinotecan; Mice; Mice, Nude; Microarray Analysis; Sulfonamides; Time Factors; Up-Regulation; Xenograft Model Antitumor Assays	2012

Article

Year

Therapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatment.

Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:5

Topics: Animals; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Camptothecin; Cell Line, Tumor; Colorectal Neoplasms; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Irinotecan; Mice; Mice, Nude; Microarray Analysis; Sulfonamides; Time Factors; Up-Regulation; Xenograft Model Antitumor Assays

2012